- PRTA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $27.7 million.
- PRTA has traded 50,642 shares today.
- PRTA is down 3.4% today.
- PRTA was up 6.5% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in PRTA with the Ticky from Trade-Ideas. See the FREE profile for PRTA NOW at Trade-Ideas More details on PRTA: Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of protein immunotherapy programs for the treatment of diseases that involve amyloid or cell adhesion in Ireland. Currently there are 4 analysts that rate Prothena a buy, 1 analyst rates it a sell, and none rate it a hold. The average volume for Prothena has been 521,100 shares per day over the past 30 days. Prothena has a market cap of $1.6 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.54 and a short float of 17.7% with 5.66 days to cover. Shares are up 164.7% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.